As is normal in Media based reporting of health / science issues that went for the hysteria.

Notice the population of the study. 1/4 not tested, just prescribed. Only 3 months duration. Only those with previous heart attacks in younger population and >65 males. But limited population who experienced negative results was not clearly communicated.

Undoubtedly, nearly all topical. No mention of estrogen control.

Same thing happens with "the little blue pill" but much less publicity on that. GO figure.

Guys go from years as a couch slug to VROOM... and little wonder some kick. Would love to see longer mortality rate study as a persons activity, including CV intensive activity tends to radically increase.

Or perhaps study should be restricted to properly treated individuals, and perhaps treatment should include education and risk mitigation... Perhaps slowly ramp up levels and activities?


Topical experience:
Marvelous for 3-9 months. frequent increased dosage. After that low absorption. All in cost $300-400 month including insurance contribution. My co-pay was $40.

after about 15 months switched to 5% compounded. MUCH BETTER and cheaper. $10-30 month. Less transfer as the application was just on wrists. Unfortunately stopped absorbing this eventually.

Now at 2x week injections at .5. Life is much better. Bottle is like $15 and lasts 3 months. Needles are a couple bucks.